Financial reports
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
25 Feb 22
10-Q
2021 Q3
Quarterly report
5 Nov 21
10-Q
2021 Q2
Quarterly report
6 Aug 21
10-Q
2021 Q1
Quarterly report
7 May 21
10-K
2020 FY
Annual report
26 Feb 21
10-Q
2020 Q3
Quarterly report
4 Nov 20
10-Q
2020 Q2
Quarterly report
4 Aug 20
10-Q
2020 Q1
Quarterly report
6 May 20
10-K
2019 FY
Annual report
2 Mar 20
Current reports
8-K
ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value
21 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
7 Jul 22
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 22
8-K
Natus Medical Announces First Quarter 2022 Financial Results
5 May 22
8-K
Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash
18 Apr 22
8-K
Natus Medical Announces Fourth Quarter 2021 Financial Results
24 Feb 22
8-K
Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
10 Jan 22
8-K
Natus Medical Announces Executive Transition
17 Dec 21
8-K
Natus Medical Announces Third Quarter 2021 Financial Results
4 Nov 21
8-K
Bryant M. Moore, Ph.D. and Eric J. Guerin Appointed to Natus Board of Directors
18 Aug 21
Registration and prospectus
15-12G
Securities registration termination
1 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
POS AM
Prospectus update (post-effective amendment)
21 Jul 22
POS AM
Prospectus update (post-effective amendment)
21 Jul 22
POS AM
Prospectus update (post-effective amendment)
21 Jul 22
25-NSE
Exchange delisting
21 Jul 22
Proxies
DEFM14A
Proxy related to merger
2 Jun 22
PREM14A
Preliminary proxy related to merger
23 May 22
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
18 Apr 22
DEFA14A
Additional proxy soliciting materials
18 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
DEFA14A
Additional proxy soliciting materials
8 May 20
DEF 14A
Definitive proxy
8 May 20
Other
EFFECT
Notice of effectiveness
25 Jul 22
EFFECT
Notice of effectiveness
25 Jul 22
EFFECT
Notice of effectiveness
25 Jul 22
SD
Conflict minerals disclosure
26 May 22
SD
Conflict minerals disclosure
27 May 21
SD
Conflict minerals disclosure
29 May 20
SD
Conflict minerals disclosure
31 May 19
UPLOAD
Letter from SEC
30 Jul 18
CORRESP
Correspondence with SEC
20 Jul 18
UPLOAD
Letter from SEC
12 Jul 18
Ownership
4
ALICE D. SCHROEDER
21 Jul 22
4
BRYANT M MOORE
21 Jul 22
4
JOSHUA LEVINE
21 Jul 22
4
Lisa Wipperman Heine
21 Jul 22
4
Eric Guerin
21 Jul 22
4
Ilan Daskal
21 Jul 22
4
Thomas Joseph Sullivan
21 Jul 22
4
Benjamin Drew Davies
21 Jul 22
4
Austin Francis Noll III
21 Jul 22
4
DONG CHUNE CHRISTOPHER CHUNG
21 Jul 22